glp-1 advertising crackdown news FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes FEDS CRACK DOWN ON TELEHEALTH

Introduction The advent of incretin-based therapies, including glucagon-like peptide-1 receptor agonists (GLP-1RAs) and their combinations, as pharmacological treatments for obesity and type 2 diabetes, has sparked intense debate about their role relative to traditional lifestyle interventions such as exercise and dietary modification

Advances in Therapy

Surprisingly, GLP-1RAs, such as liraglutide, lixisenatide, and semaglutide, have showed outstandingly neuroprotective effects on animal models of PD (63, 64)

He named Andel after a Danish and Swedish word meaning a share or a part, a reference to the member-focused cooperatives Scandinavia has been running for hundreds of years